Melatonin as a Chronobiotic with Sleep-promoting Properties.
Level 5 - mechanism / opinion, no new human data
Qualitative literature review combining mechanistic reasoning with clinical overviews.
PubMed 35176989 · doi:10.2174/1570159X20666220217152617
What was done
The authors reviewed literature on the pharmacological mechanisms, chronobiotic effects, and sleep-promoting properties of exogenous melatonin. The synthesis evaluated clinical outcomes across healthy individuals, patients with circadian rhythm sleep disorders, and patients with primary insomnia, with a specific focus on administration timing, dosage, and endogenous melatonin rhythmicity.
What was found
The abstract provides no numerical data, effect sizes, or counts of included studies. It qualitatively reports that exogenous melatonin exerts sleep-promoting and chronobiotic effects across healthy individuals, circadian rhythm sleep disorders, and primary insomnia, with outcomes dependent on the timing and dose of administration.
Why it matters
Exogenous melatonin trials have historically shown inconsistent efficacy. This review clarifies that melatonin functions primarily as a chronobiotic regulator rather than a conventional hypnotic, highlighting the need to personalize administration timing and dosage based on circadian physiology.
Limits
The abstract describes a broad review without reporting formal systematic search criteria, risk-of-bias assessments, study counts, or quantitative meta-analytic pooling. The absence of quantitative metrics prevents independent assessment of effect sizes or comparative clinical efficacy.
Cited by
- supports Melatonin functions by shifting circadian rhythm and altering levels of cortisol, epinephrine, norepinephrine, and serotonin rather than directly inducing sedation.